ABX-CBL enters late-stage clinical development following promising results in GVHD patients Dec. 10, 1999
AR-116102, a 5-HT2A receptor inverse agonist, may be the first in a new class of antipsychotics Dec. 9, 1999
Herbal extract has novel immunomodulating properties, potential in autoimmune, allergic conditions Dec. 9, 1999
RSS